Publications and reports
Below is a list of publications that use data held by the Cancer Institute NSW.
This includes:
- NSW Cancer Registry
- NSW Clinical Cancer Registry (2008–2012)
- BreastScreen NSW
- NSW Pap Test Register
- Cancer Institute Tobacco Tracking Survey
Published date 01 May 2020
In predominantly fair-skinned populations, melanoma incidence appears to differ systematically and consistently between men and women by age and anatomic site.
Published date 01 April 2020
The estimated risk of progression of lentigo maligna to lentigo maligna melanoma was 3.5% per year.
Published date 19 March 2020
The health service and diagnostic pathway to diagnosis differs markedly for people notified with CUP compared to those with metastatic cancer of known primary.
Published date 16 March 2020
The needs of prostate cancer survivors could better be met with more coordinated approaches to multidisciplinary care and timely interventions and support for chronic sexual dysfunction.
Published date 10 March 2020
The capture of anticancer medicine use by the PBS was generally high but varied depending on cancer site. PBS data can be supplemented by MBS and inpatient data, to examine ‘fact of treatment’ with a very high capture.
Published date 21 February 2020
The incidence of colon and rectal cancers has continued to increase in countries with medium to high Human Development Index scores and in younger populations.
Published date 18 February 2020
Incidence and outcomes of neuroblastoma in Australian children: a population-based study (1983-2015)
Survival for childhood neuroblastoma has improved substantially over time in Australia, but still remains lower than for most other types of childhood cancer.
Published date 13 February 2020
The growing number of cancer survivors in Australia is likely to pose complex challenges for cancer patients, their care givers, and healthcare systems.
Published date 30 January 2020
Distinct subgroups of patients were less likely to receive radiotherapy. Advocacy and/or policy changes are needed to improve access to radiotherapy.
Published date 30 January 2020
Is gastric cancer becoming a rare disease? A global assessment of predicted incidence trends to 2035
Source:
Gut. 2020 May;69(5):823-829
While gastric cancer is predicted to become a rare disease in a growing number of countries, incidence levels remain high in some regions, and increasing risks have been observed in younger generations.
